BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17138745)

  • 41. On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.
    Orlova A; Wållberg H; Stone-Elander S; Tolmachev V
    J Nucl Med; 2009 Mar; 50(3):417-25. PubMed ID: 19223403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner.
    González Trotter DE; Manjeshwar RM; Doss M; Shaller C; Robinson MK; Tandon R; Adams GP; Adler LP
    J Nucl Med; 2004 Jul; 45(7):1237-44. PubMed ID: 15235072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
    J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine-Labeled CD30-Specific AC-10 Antibody.
    Rylova SN; Del Pozzo L; Klingeberg C; Tönnesmann R; Illert AL; Meyer PT; Maecke HR; Holland JP
    J Nucl Med; 2016 Jan; 57(1):96-102. PubMed ID: 26514172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phage display and peptide mapping of an immunoglobulin light chain fibril-related conformational epitope.
    O'Nuallain B; Allen A; Ataman D; Weiss DT; Solomon A; Wall JS
    Biochemistry; 2007 Nov; 46(45):13049-58. PubMed ID: 17944486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.
    Muselaers CH; Stillebroer AB; Rijpkema M; Franssen GM; Oosterwijk E; Mulders PF; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):1035-40. PubMed ID: 24752673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy.
    Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ
    J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
    Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
    Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
    Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.
    Scheinberg DA; Straus DJ; Yeh SD; Divgi C; Garin-Chesa P; Graham M; Pentlow K; Coit D; Oettgen HF; Old LJ
    J Clin Oncol; 1990 May; 8(5):792-803. PubMed ID: 2332769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic PET and SPECT imaging with radioiodinated, amyloid-reactive peptide p5 in mice: a positive role for peptide dehalogenation.
    Martin EB; Kennel SJ; Richey T; Wooliver C; Osborne D; Williams A; Stuckey A; Wall JS
    Peptides; 2014 Oct; 60():63-70. PubMed ID: 25102446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors.
    Orlova A; Nilsson FY; Wikman M; Widström C; Ståhl S; Carlsson J; Tolmachev V
    J Nucl Med; 2006 Mar; 47(3):512-9. PubMed ID: 16513621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.
    Lachmann HJ; Gallimore R; Gillmore JD; Carr-Smith HD; Bradwell AR; Pepys MB; Hawkins PN
    Br J Haematol; 2003 Jul; 122(1):78-84. PubMed ID: 12823348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic and therapeutic potential of amyloid-reactive IgG antibodies contained in human sera.
    O'Nuallain B; Hrncic R; Wall JS; Weiss DT; Solomon A
    J Immunol; 2006 Jun; 176(11):7071-8. PubMed ID: 16709869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunotargeting of apolipoprotein E in amyloid: an initial trial in mice.
    Yamada T; Someya T; Fujita S
    Ann Clin Lab Sci; 2009; 39(2):134-7. PubMed ID: 19429798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice.
    Goldrosen MH; Biddle WC; Pancook J; Bakshi S; Vanderheyden JL; Fritzberg AR; Morgan AC; Foon KA
    Cancer Res; 1990 Dec; 50(24):7973-8. PubMed ID: 2253238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.
    Edwards CV; Rao N; Bhutani D; Mapara M; Radhakrishnan J; Shames S; Maurer MS; Leng S; Solomon A; Lentzsch S; Eisenberger A
    Blood; 2021 Dec; 138(25):2632-2641. PubMed ID: 34521113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a monoclonal rat anti-mouse Ig light chain (RAMOL-1) antibody reduces background binding in immunohistochemical and fluorescent antibody analysis.
    Brodin NT; Jansson B; Hedlund G; Sjögren HO
    J Histochem Cytochem; 1989 Jul; 37(7):1013-24. PubMed ID: 2499618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.
    van Schaijk FG; Oosterwijk E; Molkenboer-Kuenen JD; Soede AC; McBride BJ; Goldenberg DM; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2005 Mar; 46(3):495-501. PubMed ID: 15750164
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localization of 131I-labelled monoclonal antibody ERIC1 in a subcutaneous xenograft model of neuroblastoma in SCID mice.
    Otto C; Jensen M; Dietlein M; Fischer T; Schmidt M; Tawadros S; Börner SM; Weber SA; Spitz R; Bloch W; Berthold F; Schicha H; Schomäcker K
    Nucl Med Commun; 2006 Feb; 27(2):171-8. PubMed ID: 16404231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.